한글목차

세계 바이오디펜스 시장은 2025년에 177억 5,000만 달러로 추정되며, 2032년에는 294억 7,000만 달러에 달할 것으로 예상되며, 2025-2032년까지 연평균 성장률(CAGR) 7.5%로 성장할 것으로 예상됩니다.

그림. 바이오디펜스 시장 점유율(%), 2025년, 지역별

바이오디펜스는 박테리아, 바이러스, 독소, 기타 인류에 대한 무기로 사용될 수 있는 생물학적 약품 등 생물학적 위협으로부터 시민을 보호하는 것을 포함합니다. 생명공학 기술의 발전으로 인해 전 세계적으로 생물테러의 위협이 증가함에 따라 견고한 바이오디펜스 시스템의 필요성이 높아지고 있습니다. 생물테러는 병원성 미생물이나 독소를 의도적으로 사용하여 인간이나 동물, 식물에 죽음이나 질병을 유발하는 것을 말합니다. 생물무기가 점점 더 정교해지고 쉽게 구할 수 있게 됨에 따라 각국은 공중보건을 보호하기 위해 조사, 탐지, 예방, 대응책에 많은 투자를 하고 있습니다. 세계 바이오디펜스 시장은 위협 모니터링, 의료 대응책 비축 및 제공, 생물학적 위험 탐지 및 대응 훈련을 위한 혁신적인 솔루션을 제공하고 있습니다.

시장 역학

바이오디펜스 시장은 생물학적 위협에 대한 대비를 촉진하기 위한 정부 및 비정부 기관의 투자 증가에 의해 주도되고 있습니다. 전 세계적으로 생물테러 사례의 증가와 과학의 발전으로 인한 생물무기의 접근성 증가로 인해 각국은 바이오디펜스 인프라 및 비축을 강화해야 하는 상황에 직면해 있습니다. 그러나 바이오디펜스 시스템의 연구개발 및 조달과 관련된 높은 비용으로 인해 광범위한 채택을 제한하고 있습니다. 또한, 표준화된 가이드라인과 규제가 없다는 점도 시장 관계자들에게는 어려운 과제입니다. 시장에서는 새로운 병원체 탐지 기술 및 치료법에 대한 연구 개발 노력의 증가로 인해 기회를 발견하고 있습니다. 저렴한 가격의 휴대용 바이오 검출기 개발은 고위험 지역 전체에서 광범위하게 활용될 수 있는 잠재력을 가지고 있습니다.

본 조사의 주요 특징

• 세계의 바이오디펜스 시장에 대해 조사 분석했으며, 예측 기간(2024년 기준 연도, 2025-2032년) 동안의 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
• 또한, 다양한 부문에 걸친 잠재적인 수익 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 바이오디펜스 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 바이오디펜스 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사 목적과 가정

• 조사 목적
• 가정
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 규제 시나리오
• 인수와 제휴 시나리오
• 자금 조달과 투자
• PEST 분석
• Porters 분석

제4장 세계의 바이오디펜스 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• 전체적인 영향
• 정부 이니셔티브
• COVID-19의 시장에 대한 영향

제5장 세계의 바이오디펜스 시장, 제품별, 2020-2032년(10억 달러)

• 소개
• 탄저균
• 천연두
• 보툴리누스중독
• 방사선
• 기타

제6장 세계의 바이오디펜스 시장, 최종사용자별, 2020-2032년(10억 달러)

• 소개
• 병원
• 외래 진료 센터
• 연구기관
• 군사
• 기타

제7장 세계의 바이오디펜스 시장, 지역별, 2020-2032년(10억 달러)

• 소개
• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제8장 경쟁 구도

• 기업 개요
  • XOMA corporation
  • Altimmune Inc.
  • Emergent Biosolutions Inc.
  • Dynavax Technologies Corporation
  • SIGA Technologies.
  • Elusys Therapeutics Inc.
  • Ichor Medical Systems.
  • Dynport Vaccine Company.
  • Cleveland Biolabs.
  • Bavarian Nordic.
  • Ology Bioservices.
  • Alnylam Pharmaceuticals Inc
  • Takeda Pharmaceuticals
  • Chimerix, Inc.
  • Cleveland BioLabs, Inc.
  • Pluristem Therapeutics

제9장 애널리스트의 추천사항

• Wheel of Fortune
• Coherent Opportunity Map

제10장 참고문헌과 조사 방법

• 참고문헌
• 조사 방법

영문목차

Global Biodefense Market is estimated to be valued at USD 17.75 Bn in 2025 and is expected to reach USD 29.47 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2032.

Figure. Biodefense Market Share (%), By Region 2025

Biodefense involves protecting citizens from biological threats such as bacteria, viruses, toxins, and other biological agents that can be used as weapons against humanity. The rising threat of bioterrorism across the globe due to advancements in biotechnology has propelled the need for robust bio defense systems. Bioterrorism refers to the intentional use of pathogenic microorganisms or toxins to cause death or disease among humans, animals or plants. As bioweapons become more sophisticated and accessible, nations are investing heavily in research, detection, prevention and response measures to safeguard public health. The global bio defense market offers innovative solutions for threat surveillance, stockpiling and delivery of medical countermeasures, biohazard detection and response trainings.

Market Dynamics:

The bio defense market is driven by the increasing investments by government and non-government bodies to foster preparedness against biological threats. Escalating instances of bioterrorism globally and the growing accessibility of bioweapons through scientific advancement are also compelling nations to bolster their bio defense infrastructure and stockpiles. However, high costs associated with the research, development and procurement of bio defense systems limit wider adoption. Furthermore, lack of standardized guidelines and regulations pose challenges for market players. The market sees opportunities with growing R&D efforts for new pathogenic detection technologies and therapies. The development of affordable and portable bio detectors holds potential for broader usage across high-risk areas.

Key Features of the Study:

• This report provides an in-depth analysis of the global biodefense market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032, considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global biodefense market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Emergent BioSolutions, SIGA Technologies Inc., Elusys Therapeutics, Inc., Altimmune, DynPort Vaccine Company LLC.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global biodefense market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biodefense market.

Detailed Segmentation-

• By Product
  • Anthrax
  • Small Pox
  • Botulism
  • Radiation
  • Others
• By End User
  • Hospitals
  • Ambulatory Care Centers
  • Research Organizations
  • Military
  • Others
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • XOMA corporation
  • Altimmune Inc.
  • Emergent Biosolutions Inc.
  • Dynavax Technologies Corporation.
  • SIGA Technologies.
  • Elusys Therapeutics Inc.
  • Ichor Medical Systems.
  • Dynport Vaccine Company.
  • Cleveland Biolabs.
  • Bavarian Nordic.
  • Ology Bioservices.
  • Alnylam Pharmaceuticals Inc
  • Takeda Pharmaceuticals
  • Chimerix, Inc.
  • Cleveland BioLabs, Inc.
  • Pluristem Therapeutics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Biodefense Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Biodefense Market, By Product, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Anthrax
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Small Pox
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Botulism
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Radiation
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Biodefense Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Care Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research Organizations
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Military
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Biodefense Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • XOMA corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Altimmune Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Emergent Biosolutions Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Dynavax Technologies Corporation.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • SIGA Technologies.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Elusys Therapeutics Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ichor Medical Systems.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Dynport Vaccine Company.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cleveland Biolabs.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bavarian Nordic.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ology Bioservices.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Alnylam Pharmaceuticals Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Takeda Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Chimerix, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cleveland BioLabs, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pluristem Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact